Biểu đồ giá cổ phiếu MGRX
MGRX Dự đoán giá cổ phiếu
Mangoceuticals Inc
$0.47
-11.13%
$-0.05
Khi đóng cửa: Aug 18, 16:00:00 GMT-4
$0.45
-4.02%
$-0.01
Phiên sau giờ: Aug 18, 20:00:00 GMT-4
Quay lại
Mangoceuticals Inc (MGRX) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$0.5289
Giá mở cửa
$0.5049
Phạm vi ngày
$0.4511 - $0.5122
Phạm vi 52 tuần
$0.162 - $2.75
Khối lượng
1.1M
Khối lượng trung bình
9.1M
Tỷ suất cổ tức
--
EPS (TTM)
-1.61
Vốn hóa thị trường
$7.7M
MGRX là gì?
Mangoceuticals, Inc. engages in developing, marketing, and selling men's wellness products and services via a telemedicine platform. The company is headquartered in Dallas, Texas. The company went IPO on 2023-03-21. The company is advancing its proprietary antiviral compound MGX-0024. The firm offers pharmaceutical-based products specifically related to the treatments of erectile dysfunction (ED), hair growth, hormone replacement therapies, and weight management. The company has developed and is commercially marketing a brand of ED products under the brand name Mango; a brand of hair loss products under the brand name Grow; a brand of hormone balance and therapy products under the name Mojo, and a brand of weight loss products under the brand name Slim. Prime by MangoRx is a TRT product available by prescription. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin.
